Company Filing History:
1 out of 313 
1 out of 1 
1 out of 1 Years Active: 2005-2013
Title: Gennaro Citro: Innovator in Tumor Diagnostics and Treatment
Introduction
Gennaro Citro is a prominent inventor based in Rome, Italy. He has made significant contributions to the field of tumor diagnostics and treatment through his innovative research and patented inventions. With a total of 3 patents, Citro's work focuses on the development of diagnostic methods and therapeutic approaches for cancer.
Latest Patents
One of Gennaro Citro's latest patents is titled "Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits." This invention involves the creation of anti-clusterin oligoclonal antibodies that can selectively recognize and bind to specific antigenic epitopes of clusterin isoforms. These antibodies are intended for use in tumor diagnosis and predicting the malignancy grade of tumors.
Another significant patent is related to a "Peptide able to break the m-p53/p63, m-p53/p73 and m-p53/respective isoform proteins complex formed in the tumor cells and uses thereof in the pharmacological field." This invention identifies a group of peptides capable of disrupting the interaction between the mutated protein p53 and other proteins in tumor cells. The method aims to break these protein complexes in vitro, and the peptides can be used to prepare pharmaceutical compositions for treating human tumors.
Career Highlights
Gennaro Citro has worked with esteemed organizations such as the Consiglio Nazionale Delle Ricerche and the Istituto Nazionale Per La Fisica Della Materia. His experience in these institutions has contributed to his expertise in the field of cancer research and diagnostics.
Collaborations
Throughout his career, Citro has collaborated with notable colleagues, including Franco Cipriani and Giuseppe Gigli. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Gennaro Citro's innovative work in tumor diagnostics and treatment exemplifies the impact of research and invention in the medical field. His patents reflect a commitment to advancing cancer diagnosis and therapy, ultimately contributing to improved patient outcomes.